Drugs / Doxorubicinin
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06760039 Comparator | Jan 2025 → Aug 2028 expected | diffuse large B-cell lymphoma | Sun Yat-sen University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Doxorubicinin | “Doxorubicinin intravenous drip” NCT06760039 ↗ |
| Route | Intravenous | “Doxorubicinin intravenous drip” NCT06760039 ↗ |